Break-through core biopsy device with patented dual needle technology

The realization of personalized medicine is upon us as more and more cancers can be classified on their genetic signatures. These sub-types can be targeted with tailored treatments that more effectively can combat the cancer and possibly reduce the overall side effects. The most reliable material to test a potential treatment compound is an actual sample of fresh tumor.

Our innovative dual needle core biopsy instrument, Precision BX, ensures the collection of two samples directly adjacent to each other, guaranteeing homogeneity of the samples. One sample is dedicated to microscopic diagnostic evaluation, while the second is preserved for advanced genetic and molecular studies. This approach maximizes the use of valuable tissue, ensuring that only confirmed diagnostic samples proceed to expensive molecular testing—eliminating unnecessary analysis and optimizing precision medicine for better patient outcomes.